These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation. Lin L, Quan G, Peng T, Huang Z, Singh V, Lu M, Wu C. Int J Pharm; 2017 Nov 25; 533(1):84-92. PubMed ID: 28903066 [Abstract] [Full Text] [Related]
5. Effect of process variables on morphology and aerodynamic properties of voriconazole formulations produced by thin film freezing. Beinborn NA, Lirola HL, Williams RO. Int J Pharm; 2012 Jun 15; 429(1-2):46-57. PubMed ID: 22433472 [Abstract] [Full Text] [Related]
6. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride. Karimi K, Katona G, Csóka I, Ambrus R. J Pharm Biomed Anal; 2018 Jan 30; 148():73-79. PubMed ID: 28965047 [Abstract] [Full Text] [Related]
8. Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice. Beinborn NA, Du J, Wiederhold NP, Smyth HD, Williams RO. Eur J Pharm Biopharm; 2012 Aug 30; 81(3):600-8. PubMed ID: 22569473 [Abstract] [Full Text] [Related]
9. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition. Liao Q, Yip L, Chow MYT, Chow SF, Chan HK, Kwok PCL, Lam JKW. Int J Pharm; 2019 Apr 05; 560():144-154. PubMed ID: 30731259 [Abstract] [Full Text] [Related]
10. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. Shetty N, Park H, Zemlyanov D, Mangal S, Bhujbal S, Zhou QT. Int J Pharm; 2018 Jun 10; 544(1):222-234. PubMed ID: 29678544 [Abstract] [Full Text] [Related]
12. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation. Arte KS, Tower CW, Mutukuri TT, Chen Y, Patel SM, Munson EJ, Tony Zhou Q. Int J Pharm; 2024 Jan 25; 650():123698. PubMed ID: 38081559 [Abstract] [Full Text] [Related]
13. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK. Eur J Pharm Biopharm; 2016 May 25; 102():132-41. PubMed ID: 26970252 [Abstract] [Full Text] [Related]
16. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties. Duret C, Wauthoz N, Sebti T, Vanderbist F, Amighi K. Int J Pharm; 2012 May 30; 428(1-2):103-13. PubMed ID: 22414388 [Abstract] [Full Text] [Related]
17. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections. Costabile G, d'Angelo I, d'Emmanuele di Villa Bianca R, Mitidieri E, Pompili B, Del Porto P, Leoni L, Visca P, Miro A, Quaglia F, Imperi F, Sorrentino R, Ungaro F. J Control Release; 2016 Sep 28; 238():80-91. PubMed ID: 27449745 [Abstract] [Full Text] [Related]
18. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations. Jetzer MW, Schneider M, Morrical BD, Imanidis G. J Pharm Sci; 2018 Apr 28; 107(4):984-998. PubMed ID: 29247741 [Abstract] [Full Text] [Related]